References
- Crawford J., Ozer H., Stoller R., Johnson D., Lyman G., Tabbara I., Kris M., Grous J., Picolli V., Rausch G. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small cell lung cancer. N. Engl. J. Med. 1991; 325: 164–170
- Pettengell R., Gurney H., Radford J. A., Deakin D. P., James R., Wilkinson P. M., Kane K., Bentley J., Crowther D. Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkins lymphoma: a randomised controlled trial. Blood 1992; 80: 1430–1436
- Sheridan W. P., Morstyn G., Wolf M., Dodds A., Lusk J., Maher D., Layton J. E., Green M. D., Souza I., Fox R. M. Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet 1989; ii: 891–895
- Taylor K., Jagannath S., Spitzer G., Spinolo J. A., Tucker S. L., Fogel B., Cabanillas F. F., Hagemeister F. B., Souza L. M. Recombinant human granulocyte colony-stimulating factor hastens granulocyte recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkins disease. J. Clin. Oncol. 1989; 7: 1791–1799
- Linch D. C., Scarffe H., Proctor S., Chopra R., Taylor P. R. A., Morgenstern G., Cunningham D., Burnett A. K., Cawley J. C., Franklin I. M., Bell A. J., Lister T. A., Marcus R. E., Newland A. C., Parker A. C., Yver A. Randomised vehicle-controlled dose-finding study of glycosylated recombinant human granulocyte colony-stimulating factor after bone marrow transplantation. Bone Marrow Transplant. 1993; 11: 307–311
- Welte K., Bonilla M. A., Gillio A. P., Boone T. C., Potter G. K., Gabrilove J. L., Moore M. A., O'Reilly R. J., Souza L. M. Recombinant human colony stimulating factor. Effects on hemopoiesis in normal and cyclophosphamide-treated primates. J. Exp. Med. 1987; 165: 941
- Meisenberg B. R., Davis T. A., Melaragno A. J., Stead R., Monroy R. L. A comparison of therapeutic schedules for administering granulocyte colony-stimulating factor to non-human primates after high-dose chemotherapy. Blood 1992; 79: 2267–2272
- Kanfer E. Bone marrow transplant conditioning schedules. Bone Marrow Transplantation in Practice, J. Treleaven, J. Barrett. Churchill Livingstone, Edinburgh 1992; 247–256
- Nichols C. R., Andersen J., Lazarus H. M., Fisher H., Greer J., Stadtmauer E. A., Loehrer P. J., Trump D. L. High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Co-operative Oncology Group protocol. J. Clin. Oncol. 1992; 10: 558–563
- Duguid J. K. M., Baker P. K., Pender N., Clark R. E. Engraftment following transplantation of marrow leucoconcentrated by continuous flow centrifligation. Bone Marrow Transplant. 1993, in press
- Brandwein J. M., Callum J., Sutcliffe S. B., Scott J. G., Keating A. Analysis of factors affecting hematopoietic recovery after autologous bone marrow transplantation for lymphoma. Bone Marrow Transplant. 1990; 6: 291–294
- Khwaja A., Mills W., Leveridge K., Goldstone A. H., Linch D. C. Efficacy of delayed granulocyte colony-stimulating factor (G-CSF) after autologous bone marrow transplantation (ABMT). Br. J. Haematol. 1993; 84(Suppl. 1)12
- Demetri G. D., Griffin J. D. Granulocyte colony-stimulating factor and its receptor. Blood 1991; 78: 2791–2808
- Ikebuchi K., Ihle J. N., Hirai Y., Wong G. G., Clark S. C., Ogawa M. Synergistic factors for stem cell proliferation: Further studies of the target stem cells and the mechanism of stimulation by interleukin-1, interleukin-6, and granulocyte colony-stimulating factor. Blood 1988; 72: 2007–2014
- Takaue Y., Kawano Y., Reading C. L., Watanabe T., Abe T., Ninomiya T., Shimuzu E., Ogura T., Kuroda Y., Yokobayashi A., Nakahata T., Asano S., Ventura G. Effects of recombinant human G-CSF, GM-CSF, IL-3 and IL-1 alpha on the growth of purified human peripheral blood progenitors. Blood 1990; 76: 330–335
- Faulds D., Lewis N. J. W., Milne R. J. Recombinant granulocyte colony-stimulating factor (rG-CSF); pharmacoeconomic considerations in chemotherapy-induced neutropenia. Pharmacoeconomics 1992; 1: 231–249